rs104894378
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The ENST00000405440.7(TBX5):c.710G>C(p.Arg237Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R237Q) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000405440.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBX5 | NM_181486.4 | c.710G>C | p.Arg237Pro | missense_variant | 7/9 | ENST00000405440.7 | NP_852259.1 | |
TBX5 | NM_000192.3 | c.710G>C | p.Arg237Pro | missense_variant | 7/9 | NP_000183.2 | ||
TBX5 | NM_080717.4 | c.560G>C | p.Arg187Pro | missense_variant | 6/8 | NP_542448.1 | ||
TBX5 | XM_017019912.2 | c.758G>C | p.Arg253Pro | missense_variant | 7/9 | XP_016875401.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBX5 | ENST00000405440.7 | c.710G>C | p.Arg237Pro | missense_variant | 7/9 | 1 | NM_181486.4 | ENSP00000384152 | P1 | |
TBX5 | ENST00000310346.8 | c.710G>C | p.Arg237Pro | missense_variant | 7/9 | 1 | ENSP00000309913 | P1 | ||
TBX5 | ENST00000349716.9 | c.560G>C | p.Arg187Pro | missense_variant | 6/8 | 1 | ENSP00000337723 | |||
TBX5 | ENST00000526441.1 | c.710G>C | p.Arg237Pro | missense_variant | 6/7 | 1 | ENSP00000433292 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 11, 2016 | The R237P variant in the TBX5 gene has been reported previously in a father and child with Holt-Oram syndrome (Boogerd et al., 2010). The R237P variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The R237P variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. Functional studies demonstrate that R237P-TBX5 has decreased DNA-binding activity and diminished interaction with NKX2-5 (Boogerd et al., 2010). A missense variant at the same residue (R237Q) has been reported in association with Holt-Oram Syndrome (Stenson et al., 2014), supporting the functional importance of this region of the protein. We interpret R237P as a pathogenic variant. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at